Taiyo Leopoldo Harada

Dr. Taiyo Leopoldo Harada

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Radiology
Verified
Journal Article
Closed access
THTaiyo Leopoldo Harada
Taiyo Leopoldo Harada
TUTakayoshi Uematsu
Takayoshi Uematsu
KNKazuaki Nakashima
Kazuaki Nakashima
TKTakanori Kawabata
Takanori Kawabata
SNSeiichirou Nishimura
Seiichirou Nishimura
TSTakashi Sugino
Takashi Sugino
Classification of breast edema findings on T2-weighted MRI scans using the breast edema score is useful for diagnosing occult inflammatory breast cancer and can predict breast cancer prognosis. Background Prediction of occult inflammatory breast cancer (IBC) and breast cancer prognosis based on breast edema findings on T2-weighted MRI scans, even for patients without clinical signs of IBC...

15 February 2020 in European Radiology
Verified
Journal Article
Closed access
PDF file
THTaiyo Leopoldo Harada
Taiyo Leopoldo Harada
TUTakayoshi Uematsu
Takayoshi Uematsu
KNKazuaki Nakashima
Kazuaki Nakashima
TSTakashi Sugino
Takashi Sugino
SNSeiichirou Nishimura
Seiichirou Nishimura
TITakahiro Ito
Takahiro Ito

5 January 2017 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
TMTomohisa Moriya
Tomohisa Moriya
KSKazuhiro Saito
Kazuhiro Saito
YTYu Tajima
Yu Tajima
THTaiyo Leopoldo Harada
Taiyo Leopoldo Harada
YAYoichi Araki
Yoichi Araki
KTKoichi Tokuuye
Koichi Tokuuye
To evaluate the usefulness of differentiation of histological grade in hepatocellular carcinoma (HCC) using three-dimensional (3D) analysis of apparent diffusion coefficient (ADC) histograms retrospectively. The subjects consisted of 53 patients with 56 HCCs. The subjects included 12 well-differentiated, 35 moderately differentiated, and nine poorly differentiated HCCs. Diffusion-weighted imaging (b-values of 100 and 800 s/mm2) were obtained within 3 months before surgery. Regions of interest (ROIs) covered the entire tumor. The data acquired from each slice were summated to derive voxel-by-voxel ADCs for the entire tumor. The following parameters were derived from the ADC histogram: mean, standard deviation, minimum, maximum, mode, percentiles (5th, 10th, 25th, 50th, 75th, and 90th), skew, and kurtosis. These parameters were analyzed according to histological grade. After eliminating steatosis lesions, these parameters were re-analyzed. A weak correlation was observed in minimum ADC and 5th percentile for each histological grade (r = –0.340 and r = –0.268, respectively). The minimum ADCs of well, moderately, and poorly differentiated HCC were 585 ± 388, 411 ± 278, and 235 ± 102 × 10−6 mm2/s, respectively. Minimum ADC showed significant differences among tumor histological grades (P = 0.009). The minimum ADC of poorly differentiated HCC and that of combined well and moderately differentiated HCC were 236 ± 102 and 437 ± 299 × 10−6 mm2/s. The minimum ADC of poorly differentiated HCC was significantly lower than that of combined well and moderately differentiated HCC (P = 0.001). The sensitivity and specificity, when a minimum ADC of 400 × 10−6 mm2/s or lower was considered to be poorly differentiated HCC, were 100 and 54%, respectively. After exclusion of the effect of steatosis, the sensitivity and specificity did not change, although the statistical differences became strong (P < 0.0001). Minimum ADC was most useful to differentiate poorly differentiated HCC in 3D analysis of ADC histograms.

1 January 2016 in World Journal of Radiology
Verified
Journal Article
Open access
KSKazuhiro Saito
Kazuhiro Saito
YTYu Tajima
Yu Tajima
THTaiyo Leopoldo Harada
Taiyo Leopoldo Harada
Diffusion-weighted imaging (DWI) of the liver can be performed using most commercially available machines and is currently accepted in routine sequence. This sequence has some potential as an imaging biomarker for fibrosis, tumor detection/characterization, and following/predicting therapy. To improve reliability including accuracy and reproducibility, researchers have validated this new technique in terms of image acquisition, data sampling, and analysis. The added value of DWI in contrast-enhanced magnetic resonance imaging was established in the detection of malignant liver lesions. However, some limitations remain in terms of lesion characterization and fibrosis detection. Furthermore, the methodologies of image acquisition and data analysis have been inconsistent. Therefore, researchers should make every effort to not only improve accuracy and reproducibility but also standardize imaging parameters.

30 August 2017 in Acta Radiologica
Verified
Journal Article
Closed access
THTaiyo Leopoldo Harada
Taiyo Leopoldo Harada
KSKazuhiro Saito
Kazuhiro Saito
YAYoichi Araki
Yoichi Araki
JMJun Matsubayashi
Jun Matsubayashi
TNToshitaka Nagao
Toshitaka Nagao
KTKoichi Tokuuye
Koichi Tokuuye
Background: Recently, diffusion-weighted imaging (DWI) and quantitative enhancement ratio measured at the hepatobiliary phase (HBP) of Gd-EOB-DTPA–enhanced magnetic resonance imaging (MRI) has been established as an effective method for evaluating liver fibrosis. Purpose: To evaluate which is a more favorable surrogate marker in predicting high-stage liver fibrosis, apparently diffusion coefficient (ADC) value or quantitative enhancement ratio measured on HBP. Material and Methods: Eighty-three patients with 99 surgically resected hepatic lesions were enrolled in this study. DWI was performed with b-values of 100 and 800 s/mm2. Regions of interest were set on ADC map, and the HBP of Gd-EOB-DTPA–enhanced MRI, to calculate ADC value, liver-to-muscle ratio (LMR), liver-to-spleen ratio (LSR), and contrast enhancement index (CEI) of liver. We compared these parameters between low-stage fibrosis (F0, F1, and F2) and high-stage fibrosis (F3 and F4). Receiver operating characteristic analysis was performed to compare the diagnostic performance when distinguishing low-stage fibrosis from high-stage fibrosis. Results: LMR and CEI were significantly lower at high-stage fibrosis than at the low stage ( P < 0.01 and P = 0.04, respectively), whereas LSR did not show a significant difference ( P = 0.053). No significant difference was observed in diagnostic performance between LMR and CEI ( P = 0.185). The best sensitivity and specificity, when an LMR of 2.80 or higher was considered to be low-stage fibrosis, were 82.4% and 75.6%, respectively. ADC value showed no significant differences among fibrosis grades ( P = 0.320). Conclusion: LMR and CEI were both adequate surrogate parameters to distinguish high-stage fibrosis from low-stage fibrosis.

10 April 2021 in Breast Cancer
Verified
Journal Article
Closed access
PDF file
KNKazuaki Nakashima
Kazuaki Nakashima
TUTakayoshi Uematsu
Takayoshi Uematsu
THTaiyo Leopoldo Harada
Taiyo Leopoldo Harada
KTKaoru Takahashi
Kaoru Takahashi
SNSeiichirou Nishimura
Seiichirou Nishimura
ANAkifumi Notsu
Akifumi Notsu